Guidelines for Counseling Postmenopausal Women about Preventive Hormone Therapy

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Annals of Internal Medicine

• Publication date

  1992-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-117-12-1038PMID 1443972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Menopause Step-by-Step: must-know studies

  2025cites this paper
• Patient perspective: Is intensive screening of women at high risk of breast cancer evidence-based medicine or déjà vu?

  2025cites this paper
• Improving Clinical Decision Support: Architecture Design of a Multi-agent System based on an Argument Quality Assessment Ontology

  2025cites this paper
• Evolutionary Perspectives, Comparative Approaches, and the Lived Experience of Menopause.

  2025cites this paper
• Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells

  2024cites this paper
• Female reproductive factors, exogenous hormone use, and incident chronic kidney disease and end-stage renal disease.

  2024cites this paper
• The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.

  2024cites this paper
• Evolutionary Perspectives, Comparative Approaches, and the Lived Experience of Menopause.

  2024cites this paper
• The impacts of menopausal hormone therapy on longer-term health consequences of ovarian hormone deficiency

  2023cites this paper
• COUNTERPOINT: Should Asymptomatic OSA Be Treated in Patients With Significant Cardiovascular Disease? No.

  2022cites this paper
• Update on hormone therapy for the management of postmenopausal women.

  2022cites this paper
• Does publication bias explain the divergent findings on menopausal hormone therapy and cardioprotection in the literature?

  2021cites this paper
• Menopausal Hormone Therapy and the Role of Estrogen.

  2021cites this paper
• Serum ischemia-modified albumin level returns to its premenopausal level with 1-year hormone therapy in healthy menopausal women

  2021cites this paper
• The fragility of randomized trial outcomes underlying management of dyspepsia and Helicobacter pylori infections.

  2020cites this paper
• Hormonal Pathology of the Uterus

  2020cites this paper
• Effects of peripheral oxytocin administration on body weight, food intake, adipocytes, and biochemical parameters in peri- and postmenopausal female rats.

  2020cites this paper
• Hormone Replacement Therapy and Mortality for Ischaemic Heart Disease, Cerebrovascular Diseases and Breast Cancer in Italy and the U.S.A

  2020cites this paper
• Menopausal Hormone Therapy and Health Outcomes: Is Timing Everything?

  2020cites this paper
• Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study

  2020cites this paper
• In Reply.

  2020cites this paper
• Natural Hormone Replacement Therapy after Menopause by Ovarian Tissue Transplantation

  2020cites this paper
• Medroxyprogesterone Acetate

  2020cites this paper
• Hormone Therapy in Menopause.

  2020cites this paper
• Cardiovascular Disease and the Menopause

  2020cites this paper
• The Controversial History of Hormone Replacement Therapy

  2019cites this paper
• Individual Approach to Hormone Replacement Therapy – A Computer Assisted Method of Assessment of the Minimal Useful Dose

  2019cites this paper
• Korean Translation of the GRADE Series Published in the BMJ, ‘GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations’ (A Secondary Publication)

  2019cites this paper
• Lever 3: Engaging Citizens in Support of the PCIC Model

  2019cites this paper
• Deciphering the complex relationship between menopause and heart disease: 25 years and counting.

  2018cites this paper
• Will melatonin change the current attitude towards menopausal hormone replacement therapy?

  2018cites this paper
• Natural hormone replacement therapy with a functioning ovary after the menopause: dream or reality?

  2018cites this paper
• Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy

  2018cites this paper
• Evaluation of Estrogenic Activity of Extract from the Herbal Mixture Cynanchum wilfordii Hemsley, Phlomis umbrosa Turczaninow, and Angelica gigas Nakai

  2017cites this paper
• Oestrogens, progestogens and the occurrence and acceptability of vaginal bleeding

  2017cites this paper
• New evidence for cardiac benefit of postmenopausal hormone therapy

  2017cites this paper
• Safety and benefit considerations for menopausal hormone therapy

  2017cites this paper
• Quality of systematic review and meta-analysis may decide its clinical significance and publication

  2016cites this paper
• Intractable Coronary Spastic Angina Improvement after Continuous Combined Estrogen-progestin Hormonal Contraception Use in a Premenopausal Woman.

  2016cites this paper
• Recommendations for hormone therapy in hysterectomized women: importance of new data in clinical management

  2015cites this paper
• The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study.

  2015cites this paper
• Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality

  2015cites this paper
• Estrogen deficiency heterogeneously affects tissue specific stem cells in mice

  2015cites this paper
• Timing of menopausal hormone therapy and myocardial infarction.

  2015cites this paper
• Current recommendations: what is the clinician to do?

  2014cites this paper
• Spillover Effects of Drug Safety Warnings on Preventive Health Care Use

  2014cites this paper
• Coronary Heart Disease Mortality and Hormone Therapy Before and After the Women's Health Initiative

  2014cites this paper
• Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

  2013cites this paper
• Perspective on hormone therapy 10 years after the WHI.

  2013cites this paper
• GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.

  2013cites this paper
• Clinical Guidelines and Primary Care

  2012cites this paper
• Spillover Effects of Drug Safety Warnings on Health Behavior

  2012cites this paper
• The Women's Health Initiative: an unforgettable decade.

  2012cites this paper
• Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study

  2012cites this paper
• Systematic reviews to evaluate causation: an overview of methods and application

  2012cites this paper
• Knowledge and attitude of primary care doctors towards management of postmenopausal symptoms

  2012cites this paper
• Estradiol-Intranasal

  2012cites this paper
• Evidence based practice.

  2012cites this paper
• Statins and Menopause

  2012cites this paper
• Reproductive and hormonal factors and the risk of nonsmall cell lung cancer

  2011cites this paper
• Clinician decision aid for patients with hip fractures

  2011cites this paper
• Postmenopausal hormone therapy and cardiovascular disease in women.

  2010cites this paper
• Decision-making about the use of hormone therapy among perimenopausal women.

  2010influential citation
• Where postmenopausal hormone therapy stands today

  2009cites this paper
• Red Alert for Women’s Hearts

  2009cites this paper
• Vasomotor symptoms and mortality: the Rancho Bernardo Study

  2009cites this paper
• Effects of raloxifene and hormone replacement therapy on forearm skin elasticity in postmenopausal women.

  2009cites this paper
• Postmenopausal hormone treatment.

  2009cites this paper
• Postmenopausal hormone therapy and the risk of cardiovascular disease

  2009cites this paper
• Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomized female mice.

  2008cites this paper
• GRADE: An emerging consensus within the respiratory community on rating quality of evidence and strength of recommendations 1st CAnADiAn REspiRAtoRy ConfEREnCE 1st Canadian Respiratory Conference: A Breath of fresh Air

  2008cites this paper
• GRADE: an emerging consensus on rating

  2008cites this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cites this paper
• The medical management of menopause: a four-country comparison care in urban areas.

  2008cites this paper
• Utilisation de l'hormonothérapie de substitution à la ménopause : une comparaison entre des patientes en médecine de premier recours et la population générale

  2008cites this paper
• adopted by organisations worldwide GrADE : an emerging consensus on rating quality of evidence and strength of recommendations rAtING QUALItY of EvIDENcE AND StrENGtH of rEcommENDAtIoNS

  2008cites this paper
• The medical management of menopause: A four country comparison of urban care

  2008cites this paper
• Changes in postmenopausal hormone therapy use since 1988.

  2007cites this paper
• Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003

  2007cites this paper
• Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: A framework for personalized risk assessment and counseling

  2007cites this paper
• Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen

  2007cites this paper
• Implications of Recent Clinical Trials of Postmenopausal Hormone Therapy for Management of Cardiovascular Disease

  2006cites this paper
• Decision making in cancer primary prevention and chemoprevention

  2006cites this paper
• Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.

  2006cites this paper
• Menopause: evidence-based practice.

  2006cites this paper
• Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes.

  2006cites this paper
• Cardiovascular risk and hormone replacement therapy

  2006cites this paper
• Intangible Costs and Benefits of Ulcerative Colitis Surveillance: A Patient Survey

  2006cites this paper
• Use of menopausal hormones in the United States, 1992 through June, 2003

  2005cites this paper
• Endometrial Carcinoma Risks among Menopausal Estrogen plus Progestin and Unopposed Estrogen Users in a Cohort of Postmenopausal Women

  2005cites this paper
• The effect of conflict of interest on biomedical research and clinical practice guidelines: can we trust the evidence in evidence-based medicine?

  2005cites this paper
• Hormone replacement therapy, cancer, controversies, and women’s health: historical, epidemiological, biological, clinical, and advocacy perspectives

  2005cites this paper
• [Treatment of bone mass loss in postmenopausal women].

  2005cites this paper
• Gynecological health of females with congenital heart disease.

  2005cites this paper
• Attitudes and practices about postmenopausal hormone therapy among female gynecologists in Brazil.

  2005cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2005cites this paper
• Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk Information

  2005cites this paper
• Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.

  2005cites this paper
• Deciding How to Decide: What Processes Do Patients Use When Making Medical Decisions?

  2004cites this paper
• Health‐related behavior and the use of hormone replacement therapy

  2004cites this paper